Inappropriate Sepsis Therapy Leads To Fivefold Reduction In Survival
Posted on: Thursday, 5 November 2009, 13:09 CST
Patients experiencing septic shock who receive inappropriate therapy may have a fivefold reduction in survival, shows a new study. Researchers from the University of Manitoba, Winnipeg, MB, Canada, retrospectively reviewed the cases of 5,715 patients with septic shock to determine the appropriateness of initial antimicrobial therapy, clinical infection site, and relevant pathogens.
Results showed that inappropriate initial antimicrobial therapy occurred in 20 percent of patients, and the overall survival was 43.7 percent. Survival after appropriate and inappropriate initial therapy was 52 percent and 10.3 percent, respectively.
Furthermore, the decrease in survival with inappropriate initial therapy ranged from 2.3-fold for pneumococcal infection to 17.6-fold with primary bacteremia. Researchers conclude that efforts to increase the frequency of appropriateness of initial antimicrobial therapy must be central to efforts to reduce mortality from septic shock.
---
On the Net:
Related Articles
- Septic Shock: Nitric Oxide Beneficial After All
- Welchol(TM) Lowered A1C By a Mean 1 Percent or Greater When Added to Metformin-, Insulin-, or Sulfonylurea-Based Therapy in 47 Percent of Patients Evaluated
- Targeted Therapy Improves Survival Rates Among Patients With Head and Neck Cancer
- Gene Pattern Linked to Child Septic Shock
- US says Zarqawi initially survived bombing
- Gliadel(R) Wafer Demonstrates Long-Term Survival Benefit for Patients With High-Grade Malignant Gliomas
- Astra Forks Out £195m for Septic Shock Cure
- Hepatitis C Is a Predictor of Poorer Renal Survival in Diabetic Patients
- Xolair (Omalizumab) Add-On Therapy Significantly Reduces Attacks in Patients With Severe Allergic Asthma
- Chance of Surviving Septic Shock Slim
 |
 |
User Comments (0)
RSS Feeds